Literature DB >> 7714187

Evaluation of API An-IDENT and RapID ANA II systems for identification of Actinomyces species from clinical specimens.

P H Miller1, L S Wiggs, J M Miller.   

Abstract

We compared the accuracy of the An-IDENT system (bioMerieux Vitek, Inc., Hazelwood, Mo.) and the RapID ANA II system (Innovative Diagnostic Systems, Norcross, Ga.) with that of conventional biochemical tests for the identification of 85 strains of Actinomyces species. In our hands, the overall accuracy of the An-IDENT was 59% and that of the RapID ANA II was 24%. The error rate for the An-IDENT was 18% and that for the RapID ANA II was 38%. The results of this study suggest that although the An-IDENT was more accurate than the RapID ANA II (P < 0.005), neither system, in our hands, was able to identify Actinomyces species with an acceptable degree of accuracy. It is recommended that suspected Actinomyces isolates be identified by conventional testing.

Mesh:

Substances:

Year:  1995        PMID: 7714187      PMCID: PMC227942          DOI: 10.1128/jcm.33.2.329-330.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  5 in total

1.  Rapid identification of Actinomycetaceae and related bacteria.

Authors:  M Kilian
Journal:  J Clin Microbiol       Date:  1978-08       Impact factor: 5.948

2.  Evaluation of the new RapID-ANA II system for the identification of clinical anaerobic isolates.

Authors:  L M Marler; J A Siders; L C Wolters; Y Pettigrew; B L Skitt; S D Allen
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

3.  Clinical evaluation of the RapID-ANA II panel for identification of anaerobic bacteria.

Authors:  D M Celig; P C Schreckenberger
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

4.  Comparison of the PRAS II, AN-Ident, and RapID-ANA systems for identification of anaerobic bacteria.

Authors:  R S Burlage; P D Ellner
Journal:  J Clin Microbiol       Date:  1985-07       Impact factor: 5.948

5.  Evaluation of the RapID ANA II and API ZYM systems for identification of Actinomyces species from clinical specimens.

Authors:  M A Brander; H R Jousimies-Somer
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

  5 in total
  6 in total

1.  Evaluation of four commercial test systems for identification of actinomyces and some closely related species.

Authors:  Anne-Marie Santala; Nanna Sarkonen; Val Hall; Petteri Carlson; Hannele Jousimies-Somer; Eija Könönen
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

2.  Species-Level Identification of Actinomyces Isolates Causing Invasive Infections: Multiyear Comparison of Vitek MS (Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry) to Partial Sequencing of the 16S rRNA Gene.

Authors:  T Lynch; D Gregson; D L Church
Journal:  J Clin Microbiol       Date:  2016-01-06       Impact factor: 5.948

3.  Evaluation of the BBL Crystal Anaerobe identification system.

Authors:  J J Cavallaro; L S Wiggs; J M Miller
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

4.  Genotypic diversity of clinical Actinomyces species: phenotype, source, and disease correlation among genospecies.

Authors:  Jill E Clarridge; Qing Zhang
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

5.  Clinical spectrum of infections due to the newly described Actinomyces species A. turicensis, A. radingae, and A. europaeus.

Authors:  L J Sabbe; D Van De Merwe; L Schouls; A Bergmans; M Vaneechoutte; P Vandamme
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

Review 6.  Actinomycosis: etiology, clinical features, diagnosis, treatment, and management.

Authors:  Florent Valour; Agathe Sénéchal; Céline Dupieux; Judith Karsenty; Sébastien Lustig; Pierre Breton; Arnaud Gleizal; Loïc Boussel; Frédéric Laurent; Evelyne Braun; Christian Chidiac; Florence Ader; Tristan Ferry
Journal:  Infect Drug Resist       Date:  2014-07-05       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.